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ways that we cannot yet imagine. The
article bySeeley et al. highlights thecritical
importance of neural connectivity for any
principled investigation of brain function
and dysfunction. It would be a great
service to this field if funding were specifi-
cally targeted for an international collabo-
ration of cognitive neuroscientists, neuro-
imagers, and neuroanatomists so that the
real connectivity of the human brain could
be explored effectively.
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The p75 neurotrophin receptor (p75NTR) is involved in numerous neuronal signaling paths but its fundamental
signaling mechanisms are unknown. In this issue of Neuron, Vilar et al. show that p75NTR functions as a
covalently crosslinked dimer to transduce NGF-induced signaling events.The75kDaneurotrophin receptor (p75NTR)
is an important neuronal signaling protein
that interacts with numerous ligands and
coreceptors to regulate cellular survival
and apoptosis, neurite outgrowth and
repulsion, myelin formation and long-
term depression. The long list of functions
ascribed to this one receptor would be
hard to believe were it not for the compel-
ling in vivo data that demonstrates its
participation in these activities. In the
face of this biological reality, at some
point or another, almost all cellular neuro-
biologists will eventually find themselves
working a problem involving p75NTR. So
in this sense, we all have a stake in deci-
phering its mechanism of action.
p75NTR was the founding member of
the tumor necrosis family receptor
superfamily, a group that is characterized
by the presence of tandem arrays of
cysteine-rich domains (CRDs) in their
extracellular regions, which function as
ligand binding domains. TNFRSmemberstypically bind trimeric ligands of the TNF
family, whereas p75NTR binds dimeric
ligands of the neurotrophin family. The
molecular details of how neurotrophins
transduce signals via p75NTR have been
uncertain, but in this issue of Neuron, Iba-
nez and colleagues provide new insights
into the mechanisms of p75NTR signal
transduction (Vilar et al., 2009).
The authors show that p75NTR exists as
a covalently associated dimer in sympa-
thetic neurons and PC12 cells, in cortex,
hippocampus, and cerebellum, and when
overexpressed in heterologous cells. The
oligomer is lost in the presence of
reducing agents, indicating that a disulfide
linkage mediates this bimolecular associ-
ation. Each of the cysteines in the p75NTR
extracellular domain exist as intramolecu-
lar pairs that maintain the receptors’
extended structure and its intracellular
cysteines exist in a reducing environment
unable to support disulfides. So where in
p75NTR is the relevant cysteine?NeuVilar et al. (2009) identify a cysteine
residue within the p75NTR transmembrane
domain as the locus for disulfide formation
between the p75NTR chains. Introduction
of a C257A mutation into the otherwise
intact receptor blocks the formation of
the covalently linked dimer. However,
wild-type p75NTR and p75NTRC257A form
cell-surface dimers with equal frequency,
indicating that other mechanisms drive
p75NTR oligomerization. The p75NTR trans-
membrane domain also contains an
AxxxG motif at position 262–266. This
motif is present in self-associating trans-
membrane domains within integrins and
glycophorin A (Kubatzky et al., 2001) and
by using the bacterial ToxCAT system
and mammalian cell overexpression, Iba-
nez and colleagues show that the p75NTR
transmembrane domain is similarly self-
associating. Comparison of the mamma-
lian and reptilian receptor with p75NTR or-
thologs identified in primitive deutero-
stomes such as sea urchin and acornron 62, April 16, 2009 ª2009 Elsevier Inc. 3
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(A) The p75NTR transmembrane domain is conserved from vertebrates to deuterostomes such as the sea acorn (Bothwell, 2006). Transmembrane sequences are
indicated in green except for the transmembrane cysteine and glycine required for disulfide formation and transmembrane association, respectively, which are
indicated in black.
(B) In a ‘‘scissor’’ mechanism, neurotrophin binding to preformed p75NTR dimers forces a separation of the extracellular domains and thereby exposes interactor
binding surfaces in the juxtamembrane and death domain region of p75NTR.
(C) In the snail-tong mechanism, ligand binding drives p75NTR extracellular domains closer and causes p75NTR intracellular domains to move apart. Both models
allow receptors to engage the outer rim of TRAF6 oligomers.worm, reveal not only that the receptor’s
transmembrane domain is the most well
conserved region within p75NTR (Bothwell,
2006) but also that residues C257 and
G266 are almost invariably conserved
(Figure 1). Vilar et al. (2009) show that
a G266I substitution prevents transmem-
brane domain oligomerization and, there-
fore, transmembrane domain association
and disulfide crosslinking may represent
ancient features of p75NTR crucial for its
function. It seems likely that these
biochemical effects are functionally linked
such that dimerization enabled by the
AxxxG motif is a prerequisite for disulfide
formation via C257.
The concept that trimeric TNF receptor
superfamily members exist as unliganded
oligomers is well entrenched in the field.
In some of these ‘‘preligand assembly
complexes,’’ the receptor region that
facilitates oligomerization is the amino-
terminal cysteine rich domain (CRD1)
present in the extracellular domain. This
region, which has been termed the preli-
gand assembly domain or PLAD, plays
a critical role in producing oligomers of
TNFRS members such as TNFR1 and
DR5 (Chan et al., 2000; Papoff et al.,4 Neuron 62, April 16, 2009 ª2009 Elsevier In1999). CRD2, CRD3, and CRD4 and the
cleft between CRD1 and CRD2 contain
the binding surfaces that allow p75NTR to
bind neurotrophin. To date, a functional
role has not been ascribed directly to the
CRD1 in p75NTR. Previous studies have
shown that the transmembrane receptor
forms oligomers in the absence of ligand
(Wehrman et al., 2007), and the notion
that extracellular motifs, perhaps CRD1,
can promote p75NTR oligomerization is
supported by data showing that isolated
soluable extracellular domain of p75NTR
can oligomerize (He and Garcia, 2004).
However, a more recent study has found
that p75NTR extracellular domains do not
self-associate (Gong et al., 2008), and Vi-
lar et al. (2009) have found that p75NTR
containingC257AandG266I substitutions
does not show ligand-independent dimer-
ization when expressed in heterologous
cells. Thus, the CRD1 in p75NTR may be
unlikely to function as a PLAD, at least
under physiological conditions.
The AxxxG motif that drives transmem-
brane domain oligomerization in p75NTR is
not present in these other TNFR family
members (Figure 1), so it would appear
that TNFRSmembers use different strate-c.gies to achieve oligomerization in the
absence of ligand. An important issue
that remains unresolved is whether
formation of p75NTR dimers is a prerequi-
site for efficient neurotrophin binding
under physiological circumstances. Dele-
tion of the PLAD in TNFR1, TNFR2, DR4,
or DR5 prevents formation of preligand
assembly complexes and in turn, severely
compromises their ligand binding capa-
bilities (Chan, 2007). It will therefore be
interesting to test if transmembrane
substitutions in p75NTR that block dimer-
ization (e.g., C257 + G266) alter neurotro-
phin binding.
p75NTR activates an array of signaling
paths and Vilar et al. (2009) show that the
covalent association of p75NTR chains via
C257 plays a crucial role transducing
extracellular signals into intracellular
action. Comparison of wild-type p75NTR
with p75NTRC257A showed that the latter
was incapable of mediating neurotrophin-
dependent NF-kB activation, caspase-3,
cleavage or cell death. Further,
p75NTRC257A showed sharply reduced
association with NRIF and TRAF6, cyto-
solic adaptor proteins required for p75NTR
signaling. Using a robust intramolecular
Neuron
PreviewsFRET approach, Vilar et al. (2009) demon-
strate that NGF normally induces a shift in
the relative positions of p75NTR intracel-
lular domains that is lost with the
75NTRC257A mutant. Thus, the covalent
association of p75NTR via C257 appears
to invoke structural constraints on
receptor pairs necessary for the formation
of surfaces that bind adaptor proteins.
p75NTR has been cocrystallized with
neurotrophin in two recent studies but
the results obtained have been starkly
different. Wehrman et al. (2007) found
that the interaction of a p75NTR monomer
with an NGF dimer induces a structural
change in the ligand that prevents associ-
ation with a second p75NTR molecule,
whereas Gong et al. (2008) found that
neurotrophin dimers engage 2 chains of
p75NTR to produce a 2:2 ligand-receptor
stoichiometry. Although the former model
might occur in some circumstances, the
shift in the relative position of the intracel-
lular domains that occur in wild-type but
not the p75NTRC257A mutant seems more
likely if neurotrophin and p75NTR bind
with 2:2 ligand-receptor stoichiometry.
Taken together, these data suggest that
the C257-C257 disulfide bond that links
the p75NTR chains acts as a fulcrum
aroundwhich rigidp75NTR structures pivot
(Figure 1B). The specificsof how this could
occur are not known but two possibilities
are shown schematically in Figure 1. In a
‘‘scissor’’ mechanism, unliganded p75NTR
dimers exist in a relatively closed confor-
mation; neurotrophin binding then forces
a separation of the extracellular domains
and thereby exposes interactor binding
surfaces in the juxtamembrane and death
domain region of p75NTR (Figure 1B). In the
snail-tong mechanism favored by Vilaret al. (2009), neurotrophin binding acts to
pull p75NTR extracellular domains closer
and this actionpushesp75NTR intracellular
domains apart (Figure 1C). Both of these
models dovetail with earlier structural
studies that show that TRAF proteins exist
asmushroom-shaped trimers that contain
receptor binding motifs on the outer rim of
the TRAF oligomer (Ye et al., 2002).
Precisely how dimeric p75NTR complexes
might engage trimeric adaptor complexes
and how co-receptors involved in neuro-
trophin signaling, such as sortilin or the
Trks, fit into this structural picture are
important issues for further study.
In addition to functioning as a neurotro-
phin receptor, p75NTR also participates
as a coreceptor in cell-surface signaling
complexes that regulate growth come
collapse and axon guidance (Schecterson
and Bothwell, 2008). In the former,
myelin-based growth inhibitors such as
MAG bind to the NgR1 receptor and rely
on a tripartite complex of NgR1, p75NTR,
and LINGO-1 to transduce a growth inhib-
itory signal. Interestingly, the p75NTRC257A
mutant is capable of supporting MAG-
induced signaling events, indicating that
mechanisms of p75NTR signaling in NGF-
versus MAG-responsive signaling com-
plexes differ significantly. Clearly, the
downstream signaling actions of p75NTR
are strongly determined by the company
it keeps.
p75NTR has a surprisingly complex
array of actions. It induces an array of
neurotrophin-induced signaling events
and is also a promiscuous receptor that
collaborates with diverse cell surface
proteins to impinge on a large number of
neuronal functions and dysfunctions.
This complexity will only be understoodNeuwhen the molecular details of p75NTR’s
dalliances are revealed. The work of Vilar
et al. (2009) is an important step toward
that goal and provides a framework that
is certain to propel functional and struc-
tural studies that will yield further insights
into p75NTR action.
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